Oseltamivir Pharmacokinetics, Dosing, and Resistance Among Children Aged <2 Years With Influenza

Background. Children <2 years of age are at high risk of influenza-related mortality and morbidity. However, the appropriate dose of oseltamivir for children <2 years of age is unknown. Methods. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group evalu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kimberlin, David W., Acosta, Edward P., Prichard, Mark N., Sánchez, Pablo J., Ampofo, Krow, Lang, David, Ashouri, Negar, Vanchiere, John A., Abzug, Mark J., Abughali, Nazha, Caserta, Mary T., Englund, Janet A., Sood, Sunil K., Spigarelli, Michael G., Bradley, John S., Lew, Judy, Michaels, Marian G., Wan, Wen, Cloud, Gretchen, Jester, Penelope, Lakeman, Fred D., Whitley, Richard J., Giles, Dusty, Cotton, Bari, Judy, Sharon, Cowie, Margaret, Francis, Jeanne, Evans, Candice, O'Donnell, Nan, Shiraishi, Ofelia Vargas, Latiolais, Lisa, Aymami, Valeri, Dole, Ken, Gaultier, Julie, Lofthus, Gerry, Kinnunen, Diane, Lacombe, Kirsten, Stellato, Nancy, Denlinger, Julie, Hingtgen, Sara, Mason, Christina, Jeffrey, Noreen
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2013
Soggetti:
Major Articles and Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563309/
https://ncbi.nlm.nih.gov/pubmed/23230059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis765
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi